How to Buy Akero Therapeutics Stock
Akero Therapeutics Inc
Akero Therapeutics, Inc. , a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health.
Akero Therapeutics stock last closed at $37.63, up 0.51% from the previous day, and has increased 74.21% in one year. It has overperformed other stocks in the Biotechnology industry by 1.53 percentage points. Akero Therapeutics stock is currently +110.69% from its 52-week low of $17.86, and -35.57% from its 52-week high of $58.40.
There are currently 79.62M AKRO shares outstanding. The market value of AKRO is $3.00B. In the last 24 hours, 521,577 AKRO shares were traded.
How to Buy Akero Therapeutics Stock
Wondering how to invest in Akero Therapeutics stock? Here's how.
- Choose where to buy Akero Therapeutics stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Akero Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Pick your payment method and add your information.
- Analyze Akero Therapeutics stock: The Akero Therapeutics ticker symbol is AKRO. Is Akero Therapeutics stock a good investment? Should you buy shares of AKRO? How do AKRO's underlying business fundamentals look? Do top analysts think Akero Therapeutics is a good buy? Why has AKRO's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if AKRO is a good stock to buy).
- Execute your AKRO purchase: Decide if you will purchase AKRO shares at the current market price or use a limit order to buy AKRO shares at a particular price.
- Monitor your AKRO investment: Create a watchlist to keep tabs on your investment in Akero Therapeutics shares.
Step 1: Choose where to buy Akero Therapeutics stock
You need an online brokerage account in order to access the NASDAQ market and buy AKRO stock.
Our preferred brokerage: eToro
We believe that eToro is the best stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal information so you can buy AKRO stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create a new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have filled out your info on apps for stock market, you need to deposit funds:
Check out the walkthrough below if you need help depositing funds into your investment account.
Step 4: Analyze Akero Therapeutics stock
Once you have selected the best place to buy Akero Therapeutics stock, it's crucial to analyze their stock before you invest, so you can understand the risk as well as the upside.
Akero Therapeutics shares at a glance
AKRO Due Diligence Checks
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on AKRO's stock page.
Is AKRO stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge AKRO's fair value.
Using relative valuations metrics:
- AKRO may be undervalued based on its P/B ratio of 3.99x, relative to Biotechnology industry P/B ratio of 4.05x
You can access more valuation research on AKRO's stock here.
AKRO Financial Summary
Positive Health Checks:
- There are more short-term assets than long-term liabilities on the AKRO balance sheet.
- There are more short-term assets than short-term liabilities on the AKRO balance sheet.
- AKRO has cash burn of 230107000. It has enough cash and short-term investments to cover this for at least one year.
- AKRO has $743.08M in cash and short term investments. This is sufficient to cover its annual cash burn of $230.11M.
- AKRO has a low debt to equity ratio of 0.1.
Negative Health Checks:
- Total AKRO debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy AKRO stock, according to Wall Street analysts?
Out of 6 sell side analysts who give forecasts on AKRO, the consensus analyst rating on AKRO is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Latest AKRO Analyst Upgrades/Downgrades
Edward Nash, a top 13% analyst from Canaccord Genuity maintains AKRO with a strong buy rating and raises their AKRO price target from $56.00 to $73.00, on Jan 28, 2025.
Canaccord Genuity's Edward Nash raised their price target on Akero Therapeutics (NASDAQ: AKRO) by 30.4% from $56 to $73 on 2025/01/28. The analyst maintained their Strong Buy rating on the stock.
Nash told readers that they hiked their price target after Canaccord Genuity adjusted its model in response to the 96-week SYMMETRY data in F4 MASH reported by Akero Therapeutics.
The analyst explained that the positive data regarding efruxifermin was encouraging, detailing that "the strong fibrosis improvement effect of EFX demonstrated in the study could set the bar for what needs to be shown in an F4 biopsy-driven study in MASH treatment."
You can dive deeper into what analysts are saying on the Akero Therapeutics stock forecast page.
AKRO Technicals
Latest Insiders Trades at AKRO
In the past year, executives and large shareholders at AKRO have bought more shares than they have sold.
Catriona Yale, Chief Development Officer of AKRO, was the latest AKRO insider to buy. They bought $191,440.30 worth of AKRO shares on Apr 15, 2025.
Get more info about who owns AKRO stock here.
Can I rely on AKRO as an income stream?
No, Akero Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about AKRO?
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your AKRO purchase
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific dollar amount, use a limit order.
Press the Open Trade button and your broker will execute the order.
If you need more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Monitor your AKRO investment
Now that you own some shares in AKRO, you'll want to stay up-to-date on your investment.
Add AKRO to a watchlist to keep tabs on your AKRO stock.
AKRO Feed
How to Buy Stock in Akero Therapeutics
To reiterate, here are the 6 steps to buy Akero Therapeutics stock:
- Choose where to buy Akero Therapeutics stock
- Sign up for your brokerage account
- Deposit money your brokerage account
- Analyze Akero Therapeutics stock
- Execute your AKRO purchase
- Monitor your AKRO investment
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep tabs on your investment in Akero Therapeutics, add AKRO to your watchlist by clicking the button below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.